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Varicella-zoster virus (VZV) is a human herpes virus that causes varicella as a primary infection
and herpes zoster following reactivation of the virus from a latent state in trigeminal and spinal
ganglia. In order to study the global pattern of VZV gene transcription, VZV microarrays using
75-base oligomers to 71 VZV open reading frames (ORFs) were designed and validated.
The long-oligonucleotide approach maximizes the stringency of detection and polarity of gene
expression. To optimize sensitivity, microarrays were hybridized to target RNA and the extent of
hybridization measured using resonance light scattering. Microarray data were normalized to a
subset of invariant ranked host-encoded positive-control genes and the data subjected to robust
formal statistical analysis. The programme of viral gene expression was determined for VZV
(Dumas strain)-infectedMeWo cells andSVGcells (an immortalized human astrocyte cell line) 72 h
post-infection. Marked quantitative and qualitative differences in the viral transcriptome were
observed between the two different cell types using the Dumas laboratory-adapted strain.
Oligonucleotide-based VZV arrays have considerable promise as a valuable tool in the analysis of
viral gene transcription during both lytic and latent infections, and the observed heterogeneity
in the global pattern of viral gene transcription may also have diagnostic potential.
INTRODUCTION
Varicella-zoster virus (VZV) is a neurotropic alpha her-
pesvirus that causes varicella (chicken pox) as a primary
infection, and after a variable period of latency in the tri-
geminal and/or spinal ganglia, reactivates to produce herpes
zoster (shingles) (Gilden et al., 2000, 2003; Kennedy, 2002).
The most significant neurologic complication of zoster is
post-herpetic neuralgia (PHN), which affects almost half of
individuals with zoster over the age of 50 years, and is highly
refractory to treatment (Cohrs et al., 2004; Gilden et al.,
2003). The experimental approach to VZV infection has
been considerably limited by the highly cell-associated
nature of the virus and the lack of an animal model in which
VZV can be reactivated (Cohrs et al., 2004).
A detailed analysis of viral transcription both in vitro and in
vivo is important in terms of understanding the biology of
VZV, including viral latency, and in the identification of
potential viral targets that can be exploited therapeutically
(Cohrs et al., 1994, 1995, 1996, 1998, 2003a, b; Kennedy
et al., 1998, 2000). The development of gene microarray
technology in which the entire viral transcriptome can be
determined during infection has added a new dimension
to such studies. A PCR-based VZV array system using
predicted viral open reading frames (ORFs) has recently
identified highly expressed viral genes during acute lytic
infection (Cohrs et al., 2003b), and we have previously
described the use of long-oligonucleotide arrays in analys-
ing global viral gene transcription during infection by
alpha, beta and gamma members of the herpesvirus family
(Chambers et al., 1999; Ebrahimi et al., 2003; Stingley et al.,
2000; Wagner et al., 2002). Here we report the construction
and validation of a novel VZV oligonucleotide microarray
system, and show that it can be used to detect differences in
the viral transcriptome in different cell types.
METHODS
Probe design and array fabrication. Probes were designed using
the Oligo 6 primer design software (Molecular Biology Insights,
A list of VZV PCR primers is shown in Supplementary Table S1, a
summary of RT-PCR results in MeWo and SVG cells in Supplementary
Table S2, in situ hybridization using DIG-labelled probes to VZV gene
63 in VZV-infected MeWo and SVG cells at 72 h post-infection in
Supplementary Fig. S1, and gels of RT-PCR experiments for VZV
genes 31 and 61 in Supplementary Figs S2 and S3, available as
supplementary material in JGV Online.
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Table 1. VZV microarray probes
Oligonucleotide probes (75-mer) were designed based on the Dumas strain (Genbank accession no. X04370).
Gene Start End Strand Sequence (5§–3§) Position
ORF1 915 592 2 CGTTCAAACAAGACCACCGGCGGTTCTTATTCCACTGGTTGATGTCCCAAGGCCACGATCCCGGAGAAAGGCGTC 732
ORF1 915 592 2 ACTCGTCGTTCAAACAAGACCACCGGCGGTTCTTATTCCACTGGTTGATGTCCCAAGGCCACGATCCCGGAGAAA 738
ORF2 1134 1847 + TGGTGAAGCCGCACTTACCACGTCAGACCGACCCACTCTCCCAACCCTAACAGCCCAAGGAAGACCAACAGTTTC 1862
ORF2 1134 1847 + TAACATGCAACTTGACAGAAGACTCTGGTGAAGCCGCACTTACCACGTCAGACCGACCCACTCTCCCAACCCTAA 1657
ORF3 2447 1911 2 GTCCGGACAGCTGGGTGTACATCTGGCGGCTATTGGGTATCACTGTCATTGTAAATCCCCCTTCTCGGCGGAGTG 1994
ORF4 4141 2788 2 GGAAGTCACCGATTGGGCAAATGATGAAGCTATTGGCTCCACTCCAGGCGAGGACTCCACAACGTCTAGAACTGT 3969
ORF4 4141 2786 2 TGTATTACCCGATTCAAACCATCATGGAGGAAGAGACGTGGAGACTGGATATGCACGCATCGAACGGGGACATCG 3799
ORF5 5274 4255 2 CCATGCGCGTTATTATACCCCACATACATTCGGATTCTGGCCTGGGTTGTTGTATGCACGCTCGCTATAGTAGAG 4483
ORF6 8577 5329 2 TGCCCATTACGAACGTCAAGTATTGGCTGCATATCGACGACTCTACTGGGGGTATGGATGCTCGCCGTTTTGGTA 7901
ORF7 8607 9383 + AAACGTATCCGACAGAAACTCTTCAGCCCGTGTTGACCCCAAAACAGACGCAAGATGTACAACGCACAACCCCCG 9280
ORF8 10667 9480 2 CGTGTGTCCAACGGCATGGCCTGCAGGAGAACACTGTAAATTCTACGTATATAATCTCACGGGTGATGACATACG 9727
ORF9 11009 11914 + CGACCCCTCGCGTACATCAACCAAACGACTCCAGCGGATCGGAAGATGACTTTGAAGACATCGATGAAGTAGTGG 11220
ORF10 12160 13389 + CAGCGTCTGCCTTGAGGGAAATAAATTACCGCCGCCGAGAACTGGGACTGCCTCTAGTTAGATGTGGTCTTGTTG 13034
ORF11 13590 16046 + AGGAGGACGCGATCGACGACGAGGGAGAGGCGGAGGAGGATTATTTTTCTGTAAGTCAAGTTTGCAGTCGAGACG 14230
ORF11 13590 16046 + ATTGGAGACCATCTATCCCCGAGAACAGCCCATTCCCTCCGTGGACCTAGCCGAAAATCTTATGCAATACAGGAA 15917
ORF12 16214 18196 + GCGCGCGTCTGTTATTCCAGATGATTTGCTTAGACGACATTTAAAAACGGGTCCTGCGGTCTCAGCGGGCACAGG 17044
ORF13 18441 19343 + GAGATCGGGGGATATGGGCCTTGGGGTACCGTTCAACATTGCTGGATATGCACTTCTTACCTACATAGTAGCGCA 19046
ORF13 18441 19343 + GCAAACGGTGAATTATCCTGCCAAGTATACCAGAGATCGGGGGATATGGGCCTTGGGGTACCGTTCAACATTGCT 19014
ORF14 21113 19434 2 GTCCAACATCGGAACTCGACGGACCTATCACCTATTCGTGTCATCTAGATGGTTACCCTAAAAAATTCCCTCCGT 19574
ORF15 22478 21261 2 CGTCTGCGAAGCTGCCGTCAATGCAACTATTATGGGGTTGATCGTCGTTTCGGGGTTATGGCCAACATCCGTGAA 22204
ORF16 23794 22571 2 GGAAACTCCCCGAAACCACATGGCAGGAGGGAATCGGAATTCGCGAATATTGTGTGGCTCCTCCAGTGGACCCTG 22630
ORF17 24149 25513 + CCGTTTCCAAATATGCATCTAACCGATCGGAGGTGACAGTAGACGCCAGTTGGGCTTTAAACCTTCTGCCACCCT 25182
ORF18 26493 25576 2 GCGCGGACAGGCTTTTATCAGCGATTAATGTACCAAAACTATTTAACACCCCACCTCCCGATTCGGACTTTCCAC 25659
ORF19 28845 26521 2 CGGGGTCCTGGCGGCTGGGAACTTTCCATGTAAAAAATCATGTAAAGGTGTAAAAAACAACCGATCACTTGGCAT 27335
ORF20 30475 29027 2 TATAACCGCCGTGGCCAAAGGTCCCCAAGAAGCTGCACGTACAGACAAAACTTCAACTCGCAGGGTCACAGCCAA 29583
ORF21 30759 33872 + CAAGGCAGCAGTTTCATTCGTTATGGACTCCAGGCAACAGTTTATTGTGGATTCTGGACCTCAGATGGGCGCGGT 33590
ORF22 34083 42371 + GCCAAACTTTCCGCGGGACGTACACACATGGGGCGTATCTTCTAACCCGTTTAACTCACCGAACAGAGACCTATA 41993
ORF23 43138 42434 2 TCCGTTGGACAACAGCAACACGTGGTGTCGGGGTCTTCTGGACAACAACCGCAACAGGGAGCACAGTCAAGCACT 42581
ORF24 44021 43215 2 CCTGCGTTACCCGATACCCAAACTACGCGTGTCTGGAAACTTGCTCTACCCGTAGCTAACGTGACATATGCCCTG 43266
ORF25 44618 44151 2 GGAACACCATCCGGAATTAGAAGATGTATTTTCGGAGAATACGGGCGATTCGAATCCATCCATGGGTTCTTCTGA 44521
ORF25 44618 44151 2 AAGTAACGATTCAGAAAAATCTGCTTATGTTGTTCCATGTGAACATAGTGCCAGCGTGACCCGTCGCCGTGAACG 44206
ORF26 44506 46260 + CGAGCGAGGATGCCTGTCCCGAAGTAGCATTTGGGCCTATTTTGTTAACTACCTTAAAAAACGCAAAGTGCCGTG 45635
ORF27 46127 47125 + GTCGGGGGTATAAAATAGTCGCACACGTTTGGCAGACAACATTTTTACTGTCGGTATGTCGCAACCCAGAACAAC 46917
ORF28 50636 47055 2 TGGGGAAGCAAAGCGTAAGTTAATAATATCTGACTTAGCGGAAGATCCCATTCACGTAACATCACACGGGCTGTC 47350
ORF29 50857 54468 + TTTGATCGCACTCGCCGTTTTATAATAGCATGTCCTAGAGGAGGTTTTATCTGCCCCGTAACAGGTCCCTCGTCG 53911
ORF30 54651 56960 + GGCGGTGTCGTTGGTTCCAACTGGCTTCTCAGTCCATTTAGGGGCTTTTATTGCTTTTCTGGGGTAGAAGGCGTT 56538
ORF31 57008 59611 + CCGACTCGAAATACCAGATCCCGACGAAGCGTGCCAGTTGAGTTGCGTGCCAATAGAACAATAACAACCACCTCA 58274
ORF32 59766 60194 + CCTTAACCGCGACAGCCAATACGACTACTTAAACACATGTCCAGGGGGCCGTCATATTTCACTGGCACTGGAGAT 59993
ORF33 62138 60324 2 CAGTTGTGTAGGAACGACAGCGATATGGCTTCTGTAGCAGGTAACGCTAGTAATATCTCACCACAGCCCCCGTCG 61179
ORF34 63910 62174 2 AGGGGCAATAACTCTCCAGGGATTGTTTTCGGGCCATGGTATCGTACTCTGCAGGAACGGCTTGTGTTAGATAGG 63350
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Table 1. cont.
Gene Start End Strand Sequence (5§–3§) Position
ORF35 64753 63980 2 AGCTGAGGGATACCATGGCTTTAATAAAGGAAACCACACCCACGGGATCTGATGAAATAATGGTGACCCCCCTCC 64315
ORF36 64807 65829 + CATGTCTCCGTTCGTATTATCGTTAGAACAGACACCCCAGCATGCGGCACAAGAACTAAAAACTCTGCTACCCCA 65676
ORF37 66074 68596 + CGTTGTTTATTTAAGCAGGGATACTTGCGTGTCTGAACATGGTGTCATAGAGACGGTCGCACTGCCCCATCCGGA 68155
ORF38 70293 68671 2 ACGGAAAGGCATGAGTATGAGATATCCCGGTACTTAGATACCCTGTACTCTGGAGACCCCTGCTATAACGGCGCT 68848
ORF39 70633 71253 + GCGTCTCGGAACAGACAAAGGACTTGCTTAGCGTTATGGTTAACCAGCACCCCGAAGAGGACGCAAAAGTGTGTA 70652
ORF40 71540 75727 + GCGGAGGTTAACACTAATTGTAATACACTGGATCGGCTTCTAATGGAGGCAAAGGCTGTGGCGTCGCAAAGCTCC 75434
ORF41 75847 76794 + GTGGATATAGCGCTGTCGTCATATTACATTAACGGTGCTCCACCAGACACGCTCTCGCTGTTAGAGGCATACCGA 75973
ORF42 78038 76854 2 TGGCACGTCTTCCAGTGAGATAGGGCGTTGCGTTACTCAATGCTTAGGCCACATACTCGCTTTACACCCCAATAC 77344
ORF45 82593 81538 2 TATTCCACTGTTCTCGGCTACTGCTCGACGGGCAATGTTTGGCGCGTTTCTATCGTCAACAGGGTACAACTGTAC 82280
ORF43 78170 80197 + GGATGCGTTTTATAACAGCTCCTTGATGTATGCGGTTTTGGCGTATCTGTCATCTGTATATACACGACCACAAGG 79714
ORF44 80360 81448 + CCCGCGGCTTCCGAAAAATCCATACGCATGTAAAGTTATTTCTCCGGGAGTGTGGTGGTCAGACGAACGAAGGCG 80854
ORF46 82719 83315 + TTTGCGTTCCCACCACAATACCGACGGACATGAACCAAATGCAACCGCAGCCGATCAGCAAGAACGAGAATCCAC 83221
ORF46 82719 83315 + GACCCTCGATCTAATCCGTGGGGGTGCGAGTGTACAAGATCCAGCATTTGTGTATGCCTTTACTGCTGCAAAAGA 82811
ORF47 83168 84697 + CATTGGGCCAAGCACTCTTAGAAGTTATCCTGCTAGGACGTCTTCCCGGACAACTGCCCATTTCAGTACATCGGA 84261
ORF48 84667 86319 + GCGATTACATCAGCATTGCGGTCATTGCGATGGGACAATCTTCATCCAGCGGTCGAGGAGGAATCTGTGGATTGT 86197
ORF48 84667 86319 + CCTATGTATTATCCGGTTACTTTCCAGCGCTAAAACTACGGCCCTTCCTTGTCACCTTTATAGGACGTGTGCGCC 85949
ORF49 86226 86468 + ATGTAACAGAGGACGCCGATAAATCCACACAACGCCGCCCACGAGTGATCGATGTAACACCAAAACGAAAACCTT 86359
ORF50 87882 86557 2 CCGCACAAATTACCCATCACAAGGCTACGGCTACGTCTATGAAAATGACTCAACATATGAAACGGACCGCGAGGA 86615
ORF50 87882 86578 2 TGGGAACGCTCGTGGCCTGTGCTACGTTGGGAACCGCCGCGCACTCGTATATGGACCGATTATATGACCCTATAT 86908
ORF51 87881 90385 + CTGCATGTCGTACCTACCGCCAGTTGTATAACCTGCTTATGAGCCAGCGCCATTCGTTCTCTCAACAGCGTTACA 90156
ORF52 90493 92805 + CCATCGTGTGCCTGTATTCCCCCCATAGACTGCGCTGCTCATCTCAAGCCCCTTATACACACGTTTGTCACTATT 92638
ORF53 93850 92858 2 CCCCCCTGTCCAGATGGTGTGGTGCAAGTACCCCCGGGATTGTTAAATGGACCTTTACGAGATTCGGAATATCAG 92954
ORF54 95984 93678 2 TTATATGAAATGCAGGTTCGCGCAGAGGTAATAAAACGGGGCCCACGGAGAACACCAAGTCCTTCCTGGGGTTTG 93987
ORF55 95996 98638 + AGCCATGACAATTGCACGCTCACAGGGTCTGAGTTTAGAGAAGGTAGCTATCTGTTTTACGGCGGATAAACTGCG 98410
ORF56 98568 99299 + ACGGTTTACGGGTAAACAGACCTGACGATCAGACCACACCAACACCAACCCCGCACCAGTATACATCGCAAAGGC 99127
ORF57 99626 99414 2 TGTACGCGAGTTAATTTTGTCGGGACACAACAACGTCGTATTACAGACATACACTGGTAAATGGTCAGACTGCCG 99484
ORF58 100272 99610 2 GAGCCTGCAAATGTTTGTGTTGTGTCAAAAAACCCATGCACCCCGTGTCAGAAACCTACTGTACGAGAGTATTCG 99785
ORF59 101219 100305 2 TGTGGGGTGCGCATGCACAGAAGACAACCCAACCGAATTCAAGATGTCATCTGGTGCTAACACACGCGCATCCGT 100406
ORF60 101649 101173 2 CGGGGACATACGCGATGCTTTGTTGGATGCCCTTTCCGGTGTATGGGTAGACTCTACTCCATCTTCCACAAATAT 101228
ORF61 104485 103085 2 AAGACCAGAAACCACCTCAACCGGGGAGACCTCTCGTGGCGATGAAAGGGATACCCGATTGGTAAATACACCCCA 103377
ORF62 109133 105204 2 GCTCGTATCGAGACTGCGTTTGCCAACCTGTACCCGGGCGAACAACCCCTGTGTTTGTGCCGCGGTGGGAACGTC 106032
ORF62 109133 105204 2 ATAGCATGGCTCCAGAACCCCAAGCTGACCGGTGTCAACTCGGCCCTGAACCAGTTCTACCAAAAGCTGTTGCCA 107499
ORF63 110581 111414 + TTTGCATAGGAGCGCACTGGAATGTGACGTATCTGATGATGGTGGTGAAGACGATAGCGACGATGATGGGTCTAC 111018
ORF64 111565 112104 + GAATTATATGACCGCCCCGGGGGAATTTGTCACAGGCTTTTTGACGCGTACCTGGGCTGCGGGTCCCTTGGAGTC 12099
ORF65 112640 112335 2 CGTTCGGCTGAAAAGTGTTATTATAGTGATAGCGAAAATGAAACGGCAGATGAATTTTTGCGTCGAATTGGAAAA 112455
ORF66 113037 114215 + CGGCCACCGAGGCAACCGTGTTAAGAGCGTTAACCCACCCATCCGTTGTACAGCTTAAAGGAACGTTTACGTATA 113422
ORF67 114496 115558 + CCAAATACAAAAACAAGAAGGGGCATACAAAATGCGACACCAGAATCCGATGTGATGTTGGAGGCCGCCATTGCA 115423
ORF68 115808 117676 + CCCAACGCACCCCAATGCCTCTCTCATATGAATTCCGGTTGTACATTTACCTCGCCACATTTAGCCCAGCGTGTT 117005
ORF69 118332 117793 2 GCCCGATAATAAATGCATCCGCGCCGAATTATATGACCGCCCCGGGGGAATTTGTCACAGGCTTTTTGACGCGTA 117839
ORF70 119316 118483 2 CATAGGAGCGCACTGGAATGTGACGTATCTGATGATGGTGGTGAAGACGATAGCGACGATGATGGGTCTACGCCA 118801
ORF71 120764 124693 + GGGAGATCCGGCTAGACAGTACCGCGCGCTGATTAACCTGATCTACTGTCCAGACAGAGACCCTATAGCATGGCT 122320
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http://www.oligo.net/contact.htm). ORF- and strand-specific viral
probe sequences were based on the original sequencing data
(Davison & Scott, 1986), in which 71 ORFs, located on both strands
(Dumas strain), were identified (Table 1), Genbank accession no.
X04370. Design parameters for probe selection included: 75 base
length, 85–95 uC melting temperature, 145–111 kcal mol21 (607–
465 kJ mol21) DG, 45–55% GC content, <1000 bases from 39 end,
<1?5 kcal mol21 (<6?3 kJ mol21) loop DG. Control elements on
the array included 10 probes for cellular housekeeping genes, 18
negative-control probes (unrelated Arabidopsis thaliana genes), and
printing vehicle without nucleic acids (Table 2). Probes were synthe-
sized by MWG-biotech, resuspended at 100 mM in printing buffer
(final concentration of 150 mM phosphate, 0?01% SDS) and roboti-
cally printed in triplicate using a Genomic Solutions MG2 arrayer
(with 46 MicroSpot 2?5K split pins) onto c-aminopropylsilane
(GAPS) II-coated slides (Corning Inc.). Arrays were stored under
nitrogen at room temperature prior to use.
Viruses and cell lines. MeWo cells (a human melanoma cell line)
were grown in Gibco 1966 DMEM medium containing glutamine,
non-essential amino acids, 10% fetal calf serum (FCS) and gentamicin.
A total of 36106 MeWo cells were mixed with an equal number of
MeWo cells infected with VZV (Dumas strain) and grown in T175
flasks. By 72 h a viral infection was achieved, but no plaque forma-
tion was seen with this strain on MeWo cells. The SVG cell line is a
human astroglial cell line (Major et al., 1985) and was a generous
gift from Dr E. O. Major. VZV-infected cells and uninfected SVG
cells infected with VZV were treated in a similar manner to MeWo
cells, except that the medium used for SVG cells was MEM contain-
ing Earle’s salt, glutamine, gentamicin and 10% FCS. In addition,
with the Dumas strain of virus, plaques are formed in SVG cells. To
obtain the results reported below, a total of five 250 ml flasks of
VZV-infected and five flasks of non-infected MeWo cells and SVG
cells were harvested at 72 h when the observed cytopathic effects
(CPEs) were maximal and similar in both cell types. The pooled
data from these experiments were then statistically analysed to
obtain the final results.
Isolation of RNA. RNA was extracted from cells using Qiagen
RNeasy kits. Approximately 107 cells were trypsinized from the flasks
and resuspended in lysis buffer containing b-mercaptoethanol. The
samples were placed on a QIAshredder spin column and centrifuged
Table 2. Microarray probes for human housekeeping genes and negative controls
(a) Ten 75-mer oligonucleotide probes were designed for cellular transcripts. The array also included probes for (b) eighteen Arabidopsis
thaliana genes.
Accession no. Sequence (5§–3§)
(a)
AJ000099 GTGACGCGGGGTACACCACAAGCACGGAGACCTGCCAGTACCTCAAAGATTACCTGACACGGCTGCTGGTCCCCT
D84361 AAGGACAGAGTCTTTGACAGTATCAGCCACCTCATCAACCACCACCTAGAAAGCAGCCTGCCCATTGTCTCTGCA
J04038 AACATGGAAGAAGCTATTCTGTGGGCAGCCCCAGGGAGGCTGACAGGTGGAGGAAGTCAGGGCTCGCACTGGGCT
J04617 AATAGGTCGCTTTGCTGTTCGTGATATGAGACAGACAGTTGCGGTGGGTGTCATCAAAGCAGTGGACAAGAAGGC
K00558.1 CCGTGAAGATATGGCTGCCCTTGAGAAGGATTATGAGGAGGTTGGTGTGGATTCTGTTGAAGGAGAGGGTGAGGA
M60854 AGGAGCGATTTGCTGGTGTAGACATCCGTGTCCGTGTAAAGGGTGGTGGTCACGTGGCCCAGATTTATGCTATCC
U02629 CCGCATGGTGCTGAATGGCTGAGGACCTTCCCAGTCTCCCCAGAGTCCGTGCCTTTCCCTGTGTGAATTTTGTAT
X00351 CCCCAAGGCCAACCGCGAGAAGATGACCCAGATCATGTTTGAGACCTTCAACACCCCAGCCATGTACGTTGCTAT
X58536 CGTGTCCACCGTGACCCCTGTCCCCACACTGACCTGTGTTCCCTCCCCGATCATCTTTCCTGTTCCAGAGAAGTG
Z12962 TCGCCCTCTGATCGCCGATCACCTCTGAGACCCACCTTGCTCATAAACAAAATGCCCATGTTGGTCCTCTGCCCT
(b)
AY045834 AATAAGTATAGGTCTTGGTCCTTCGGGGGAGCTTAGATATCCTGCACATCCTTCTGGAGATGGGAGGTGGAAATT
AY062116 ATTTACCTGTTGAAGAGAAAGCTGAGCTCAATTCTTTGCAGAGAGGCAGCAGGCTTGTAGCTTCCGGTTATGTGC
M90394.1 CCTAGGTCCTAAGTCTTTTTACTTGCAACCAAAGGGCATTTTGGTCGTTTTTTAAGTTTCATGGACCAGATATGC
U09332.1 AAGAGAAGGTACCTCCGGTGGTGGTTGCGGAGATGACCTTGACATCACTCTAGATAGATCTTCCTCACGTGGAAC
U91966.1 TCTATCTGGTGGAGATCATATTCACGCGGGTACAGTAGTAGGTAAACTTGAAGGAGACAGGGAGTCAACTTTGGG
X14212.1 CGTATGGGTGGTACTACTCAGTACACTGTCAACAACCAGATGGTTAACGCAACACTCATGAACATTGCTGATAAC
X56062.1 CTTCTCTCTTCTTCCAAGTCTAAATTCGTATCCGCCGGAGTTCCACTCCCAAACGCCGGGAATGTTGGTCGTATC
X68145.1 GACCTTCAAAGATCACAGTACTCTCAATCCGAAGCAGAAGCAAGCATTGGCTAAACAATTAGGGTTACGAGCAAG
AF159801* SR4_LTP4
AF159803* SR5_LTP6
AF168390* SR7_RCP1
AF191028* SR6_XCP2
AF198054* SR8_NAC1
AF247559* SR9_TIM
U91966* SR3_rbcL
X14212* SR2_RCA
X56062* SR1_CAB
X58149* SR10_PRKase
*Stratagene ‘SpotReport Oligo Array Validation System’ proprietary sequences (catalogue no. 252170).
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at maximum speed for 2 min. An equal volume of 70% ethanol was
added to the flow-through which was placed on the Qiagen column,
washed and then DNase (Qiagen RNase-free DNase) was added to
the column. After several washes, the RNA was eluted and it was
usually necessary to DNase-treat again (DNA-free kit, Ambion). The
absence of residual DNA was shown by PCR for b-actin. RT-PCR
was performed on all samples, and as a further check for DNA con-
tamination, PCR was also performed on samples which were not
reverse transcribed. RT-PCR also provided a validation for the pre-
sence of VZV-specific RNAs. Primers for VZV genes 37 (late, L), 28
(early, E) and 63 (immediate early, IE), as well as 62 (IE), 10 (L), 31
(L) and 4 (IE) were used, as well as nested primers for genes 63 and
62 (refer to Supplementary Table S1 for all VZV PCR primers used
in this study). All of these VZV genes could be detected by RT-PCR
(gels of RT-PCR experiments for VZV genes 31 and 61 are shown in
Supplementary Figs S2 and S3).
The total RNA samples were quality-control checked on 2100 Bio-
analyser NanoChips (Agilent) and a BioMate 5 UV spectrophotometer
(Thermo Spectronic).
Array hybridization. Biotin [-dUTP (50 nmol), Roche Diagnostics]
-labelled cDNA was synthesized from 2?5 mg total RNA, as specified
by the manufacturer (Protocol for Direct Labelling for cDNA with
Biotin-dUTP, Qiagen). The biotinylated target cDNAs were hybri-
dized to the arrays (18 h at 42 uC), washed, HiLight Resonance Light
Gold Particle hybridized (1 h at room temperature) and washed, as
specified by the manufacturer (HiLight Array Detection Protocols
– For Single-Colour Detection on the HiLight Reader using
Resonance Light Scattering, Qiagen).
Data processing and statistical analysis. Array hybridization
and analysis followed standard operating procedures, as described
by Forster et al. (2003). Array data can be accessed at the MIAME-
compliant database GPX, accession no. GXE-00039 (http://www.
gti.ed.ac.uk/GPX/).
Image quantification. QUANTARRAY (Packard Biosciences) image
analysis software (with ‘histogram quantification’ correction) was
used for initial data capture. A typical hybridization image is
shown in Fig. 1. To define the linear dynamic range of the biotin–
gold particle light scatter and to control for scanning parameters
(exposure time of the white-light source), arrays were scanned at
five increasing exposure times, thereby initially generating five
datasets per array. These datasets were then analysed against each
other by scatter plots. The scan with the highest linear range of
expression but no genes saturated at the 16-bit scan limits (maxi-
mum intensity value=65535) was chosen as the dataset best repre-
senting an array.
Noise correction. Any localized array background variation was
corrected for by subtracting the individual background intensity
from the expression value for each gene.
Print quality correction. Triplicate printing of each probe on an
array allowed us to compute the median expression value of each
such triplicate as the representative value for this gene.
Array quality control. Receiver-operating-characteristics (ROC) analy-
sis was performed for each array hybridization in the study. Sets
of known positive- (n=30) and negative-control probes (n=156,
including unused spike controls) on the chip represented the ‘gold
standard’, against which the expression values were compared. The
area under curve (AUC) was calculated for each array. Clear distinc-
tion (AUC close to 1) of positive and negative controls was taken to
be an indicator of array/hybridization quality, since a high value
meant that the expression values for known positive- and negative-
control probes did not overlap. An AUC close to 0?5 would indicate
that there is no expression-level cut-off that can clearly distinguish
between positive and negative signals. As a consequence, one biological
replicate from the non-infected MeWo cell line was withdrawn from
analysis.
(a) (b)
Fig. 1. Typical QUANTARRAY (Packard Biosciences) image with grid overlay of (a) MeWo cells infected with Dumas strain for
72 h and (b) uninfected MeWo cells.
http://vir.sgmjournals.org 2677
Microarray analysis of VZV transcription
Data transformation. Following the above, for further processing,
the log2 of all data was obtained.
Normalization. The chosen method was scaling of the array medians
to a common reference value by adding a correctional constant
(Forster et al., 2003). Normalization estimates were based on a set of
host-encoded housekeeping genes (n=30), because a global normal-
ization method based on the distribution of all probes on the array
is inappropriate for most targeted (i.e. genome subset) arrays. For a
targeted array, it can be assumed that a large proportion of genes
will change expression between uninfected and infected samples; any
overall expression differences between different samples are therefore
due to hybridization/scanning and to real biological differences.
All 30 housekeeping spots were assessed for consistency by means of
a k-means clustering on their raw expression values across all arrays.
As a result of this, the most reliable and rank-invariant set was
chosen as the normalization set (n=12) accounting for hybridiza-
tion/scanning effects only. These are triplicate spots of probes repre-
senting major histocompatibility complex 1 (MHC1), a-tubulin,
glyceraldehyde-3-phosphate deydrogenase (GAPDH) and myosin
light chain (alkali) Alt. Splice2.
Measurement thresholding. Subsequent to normalization, the
lower threshold for reliable measurement of gene-expression values
was computed as the 80th percentile of signal intensities of the
Arabidopsis thaliana negative controls (n=1863). This threshold
level was used to determine whether a signal was above the detection
error associated with each individual array. The threshold level value
was subtracted from the expression value for each ORF. In tables
and figures, a value lower than 0 is represented as a 1.
Inference analysis. Statistical comparisons were performed for each
gene to determine the significance of differential expression between
infected and uninfected samples. The statistical sample size was n=5
independent biological samples per group, except for the MeWo
non-infected group, for which n=4 (see Methods). Although suffi-
cient for the computation of test statistics, a per-condition sample
size of five limited the direct biological interpretability of results
without laboratory validation. However, this study did include RT-
PCR measurements as a means of validating the microarray results.
Interpretation of results was done on the premise that the signifi-
cance tests serve as a valid ‘interest filter’. To make optimum use of
the microarray platform and the given sample sizes, the method of
analysis was a permutation of Welch’s t test performed on log2-
transformed data. A Westfall and Young step-down adjustment was
used on the resulting P values to correct for problems created by
testing multiple genes simultaneously.
RESULTS AND DISUSSION
In the present study, a total of 40 chip hybridizations were
analysed. The collective results can be used in conjunction
with probe classification to assess the overall validity of the
microarray approach. Data on signal values of the grouped
array data are shown in Fig. 2 as a box-and-whiskers plot for
each of the classes of gene probes on the array: negative
controls, ORFs and positive controls. A comparison of
uninfected with infected samples led to the development of
a response profile that highlights the whole-scale expres-
sion of viral transcription at 72 h, whereas the cellular and
negative probes remain by and large unaffected. The plots
give a numerical and statistical representation of the res-
ponse profile of the probe sets, and thereby provide valid-
ation data for the VZV arrays, in which all probe classes
behaved as expected. The comparative analysis has been
performed after using a set of invariant housekeeping genes
in a form of ‘subset’ normalization, as a reference point for
the various respective samples.
To evaluate the sensitivity and specificity of the VZV
microarrays in a quantitative manner, ROC analysis was
(a) (b)
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Fig. 2. Box-and-whiskers plots of VZV microarray validation. All spotted probes were placed into three groups (negative
controls, ORFs and positive controls) to visualize their overall log-transformed signal intensities. The median value is
represented by the line inside the box. Above this line are data in the third quartile and below this line are data in the first
quartile. (a) MeWo non-infected (the outlying probes in the ORFs group are ORFs 10, 59, 60 and 63); (b) MeWo 72 h
infected (Dumas strain).
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performed for each array hybridization in the study (see
Methods). Fig. 3 shows a representative graph containing
all array hybridization ROC curves for non-infected and
infected MeWo and SVG at 72 h. An AUC of 1 implies no
overlap in expression values between negative and positive
controls, whereas an AUC of 0?5 indicates the negative and
positive probes are not distinguishable by their expression
values. The mean AUC value for all tissue-culture experi-
ments was 0?92. VZV infection of clinically obtained cell
culture samples (ROC not shown) yielded a mean AUC
of 0?81. As expected, variation is evident between replicate
samples, which underscores the statistical use of replication
in array experiments.
Unlike other members of the herpesvirus family, VZV is
particularly difficult to grow in culture. Accordingly, infec-
tions are limited to virus-infected cell-passaged stocks, and
quantification of virus is far more difficult than is the case
with herpes simplex virus (HSV). In addition, unlike other
alpha herpes viruses, such as HSV, it would be very difficult
to synchronize the infection of cells with VZV. Since Cohrs
et al. (2003b) have shown that the relative expressions of the
transcripts are similar at different time points, we focused on
the time of maximum CPE and extended their results by
comparing the transcriptomal pattern in two different cell
lines: MeWo, a human melanoma cell line, and SVG, a
human astroglial cell line. The first array experiments were
carried out on virally infected MeWo cells, one of the most
permissive cell types for VZV replication. The accumulated
results for these experiments at 72 h using the laboratory
Dumas VZV strain are shown in detail in Table 3. There was
a highly significant detection of the expression of 68/71 viral
genes. The greatest expression detected was that of ORF 57,
followed by (in order of extent of expression) ORFs 9, 49, 58,
48 and 69. The only ORFs whose expression was not signi-
ficant were 6, 22 and 56.
When the transcriptional profile of the Dumas VZV strain in
SVG cells at 72 h was studied, the results showed a marked
contrast to those observed in MeWo cells. The accumulated
results in SVG cells are shown in detail in Table 4. Only 20/
71 VZV ORFs showed a highly significant expression in
infected SVG cells, with the greatest expression observed for
ORFs 24, 68, 61, 13, 32 and 53. A comparison of the highly
significant signal intensities of the viral genes in MeWo cells
compared with the signal intensities of the same genes in
SVG cells at the same time-period is shown in Table 5,
which also lists the known or putative functions of those
ORFs. The only ORFs in the ‘top six’ expressed genes in
MeWo cells that were also expressed in SVG cells were 49, 57
and 58. However, none of the top six expressed genes in
MeWo cells can be found in the top six expressed genes in
the SVG cells after viral infection. Analysis of the intensity
ratio between the mean of the top 20% expressed viral genes
compared with the mean of the invariant cellular genes
indicated similar ratios of between 1 : 1 and 1 : 1?5 in SVG
and MeWo cells, respectively. These results showed clearly
that the infected cell type strongly influences the VZV
transcriptome, which likely relates to the state of permis-
siveness of the cellular system. It was obviously important to
study MeWo and SVG cells that had an equivalent level of
infection at 72 h, as otherwise any detected differences seen
Fig. 3. Quality control by ROC analysis. One ROC analysis was performed for each array hybridization in the study. This is a
representative graph containing all ROC curves for (a) MeWo and (b) SVG non-infected and infected at 72 h arrays. Sets of
known positive- (n=30) and known negative-control probes (n=156) represent the ‘gold standard’ against which expression
values are compared. An AUC of each array is shown.
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on the arrays might have been due to initial differences in
infection levels. The level of infection in the two cell lines at
72 h was indeed comparable, with approximately 90% of
MeWo cells and 80% of SVG cells infected, as assessed by
the level of CPE and by in situ hybridization using a VZV
gene probe (Supplementary Fig. S1).
It was also important to confirm the detection of specific
VZV ORF expression on the arrays by a different method.
We therefore used RT-PCR to examine the presence of a
range of representative VZV genes (ORFs 4, 10, 28, 31, 37, 62
and 63) at 72 h after infection in both MeWo and SVG cells.
While not all of these genes had been shown to be signi-
ficantly expressed on the arrays in the two culture systems,
we were able to detect the presence of all of these genes by
RT-PCR (representative gels are shown in Supplementary
Figs S2 and S3). We strongly suspect that this is due to the
greater sensitivity of RT-PCR compared with microarrays,
even though the latter have the considerable advantage of
examining the expression of the entire VZV genome simul-
taneously. Evidence for this explanation was provided by
our semi-quantitative arbitrary assessment of the intensity
of the gel bands for representative VZV ORFs 31, 37, 61 and
62 in MeWo cells compared with SVG cells [see Supple-
mentary Table S2, in which Quantity One 1-D analysis
Table 3. Fold change of signal intensities for the viral tran-
scripts of VZV Dumas-infected (72 h post-infection) MeWo
cells and non-infected MeWo cells
The table also contains significance P values. **, P value<0?05.
The fold changes are from absent to present. Zero signal intensi-
ties were therefore given an arbitary value of 1 before the fold
changes were calculated.
ORF Fold change for infected
(72 h Dumas) versus uninfected
MeWo cells (standard error)
Westfall &
Young P value
ORF01 8?88 (0?32) **
ORF02 6?07 (0?36) **
ORF03 7?45 (0?37) **
ORF04 12?03 (0?38) **
ORF05 5?08 (0?45) **
ORF06 0 (0?43)
ORF07 11?34 (0?34) **
ORF08 10?10 (0?31) **
ORF09 14?48 (0?41) **
ORF10 4?63 (0?41) **
ORF11 11?44 (0?36) **
ORF12 10?24 (0?35) **
ORF13 8?69 (0?37) **
ORF14 11?54 (0?34) **
ORF15 10?29 (0?33) **
ORF16 9?29 (0?42) **
ORF17 9?90 (0?43) **
ORF18 12?30 (0?32) **
ORF19 4?48 (0?35) **
ORF20 10?47 (0?36) **
ORF21 10?65 (0?44) **
ORF22 6?77 (0?45)
ORF23 13?82 (0?37) **
ORF24 13?41 (0?41) **
ORF25 10?50 (0?34) **
ORF26 9?46 (0?34) **
ORF27 11?15 (0?34) **
ORF28 11?93 (0?34) **
ORF29 11?97 (0?46) **
ORF30 8?29 (0?46) **
ORF31 10?50 (0?36) **
ORF32 12?71 (0?39) **
ORF33 13?05 (0?42) **
ORF34 9?50 (0?38) **
ORF35 8?19 (0?45) **
ORF36 11?99 (0?49) **
ORF37 12?98 (0?47) **
ORF38 12?56 (0?39) **
ORF39 8?91 (0?38) **
ORF40 6?16 (0?36) **
ORF41 12?81 (0?33) **
ORF42 11?87 (0?31) **
ORF43 9?29 (0?33) **
ORF44 10?99 (0?37) **
ORF45 5?75 (0?38) **
ORF46 4?75 (0?46) **
Table 3. cont.
ORF Fold change for infected
(72 h Dumas) versus uninfected
MeWo cells (standard error)
Westfall &
Young P value
ORF47 11?36 (0?35) **
ORF48 13?97 (0?48) **
ORF49 14?32 (0?34) **
ORF50 12?48 (0?34) **
ORF51 10?10 (0?40) **
ORF52 12?02 (0?40) **
ORF53 12?73 (0?41) **
ORF54 10?33 (0?46) **
ORF55 8?60 (0?52) **
ORF56 3?56 (0?48)
ORF57 14?49 (0?44) **
ORF58 14?26 (0?37) **
ORF59 5?25 (0?38) **
ORF60 3?54 (0?40) **
ORF61 13?52 (0?37) **
ORF62 7?16 (0?35) **
ORF63 5?95 (0?39) **
ORF64 9?48 (0?37) **
ORF65 11?47 (0?36) **
ORF66 10?24 (0?33) **
ORF67 13?67 (0?34) **
ORF68 10?44 (0?40) **
ORF69 14?18 (0?37) **
ORF70 13?64 (0?34) **
ORF71 10?66 (0?31) **
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software (Bio-Rad) was used]. While the signal intensity of
the bands was always greater inMeWo than in SVG cells, the
signals for ORF 61, which was expressed on arrays in both
MeWo and SVG cells, were very similar in both cell types.
However, the intensity of the bands for ORF 31, which was
expressed on arrays in MeWo but not SVG cells, was higher
in MeWo cells than in SVG cells.
The array design used probes with a high degree of bio-
physical and thermodynamic equivalence, and allowed the
determination of both the stringency and polarity of viral
gene expression. The latter was also quantified using robust
statistical analyses. A comparison of our results with the
recent study of Cohrs et al. (2003b) reveals that the tran-
scription of some viral genes was significantly elevated in
both systems. Thus, there was a striking detection of the
transcription of VZV ORF 9 in MeWo cells infected with
VZV, this gene being consistently highly transcribed in
lytically infected cultures. This is the first independent
confirmation of the finding of Cohrs et al. (2003b) that ORF
9 is the most highly expressed ORF in BSC-1 cells infected
with the VZV Ellen laboratory strain. This protein is
known to be an abundant tegument phosphoprotein, the
protein being phosphorylated by the ORF 47-encoded
protein kinase (Ng & Grose, 1992; Ng et al., 1994), and then
associating with phosphorylated IE 62 protein (Spengler
Table 4. Fold change of signal intensities for the viral tran-
scripts in VZV Dumas infected (72 h post-infection) SVG
cells and non-infected SVG cells
The table also contains significance P values. **, P value <0?05.
The fold changes are from absent to present. Zero signal intensi-
ties were given an arbitary value of 1 before the fold changes were
calculated.
ORF Fold change for infected
(72 h Dumas) versus uninfected
MeWo cells (standard error)
Westfall & Young
P value
ORF01 7?96 (0?68)
ORF02 1?33 (0?54)
ORF03 3?30 (0?63)
ORF04 10?31 (0?54)
ORF05 7?15 (0?95)
ORF06 5?86 (0?66)
ORF07 8?66 (0?43)
ORF08 8?24 (0?74)
ORF09 4?51 (0?76)
ORF10 1?71 (0?84)
ORF11 4?22 (0?81)
ORF12 7?55 (0?58)
ORF13 10?37 (0?72) **
ORF14 7?54 (0?59)
ORF15 8?60 (0?77)
ORF16 6?45 (0?99)
ORF17 7?67 (0?58)
ORF18 9?69 (0?87) **
ORF19 20?27 (0?90)
ORF20 9?46 (0?85) **
ORF21 1?14 (0?90)
ORF22 9?32 (0?63)
ORF23 3?44 (0?61) **
ORF24 11?09 (0?48) **
ORF25 8?42 (0?59)
ORF26 6?32 (0?74)
ORF27 9?15 (0?56)
ORF28 9?61 (0?55)
ORF29 8?96 (0?74) **
ORF30 7?64 (0?72)
ORF31 7?81 (0?49)
ORF32 10?41 (0?47) **
ORF33 7?86 (0?67) **
ORF34 6?70 (0?67)
ORF35 5?40 (0?73)
ORF36 9?53 (0?68)
ORF37 5?02 (0?53) **
ORF38 9?58 (0?55)
ORF39 5?89 (0?57)
ORF40 7?86 (0?45)
ORF41 9?92 (0?89)
ORF42 9?28 (1?17)
ORF43 5?01 (0?66)
ORF44 7?40 (0?53)
ORF45 7?54 (0?60)
ORF46 4?16 (0?64)
Table 4. cont.
ORF Fold change for infected
(72 h Dumas) versus uninfected
MeWo cells (standard error)
Westfall & Young
P value
ORF47 8?77 (0?68) **
ORF48 3?68 (0?55)
ORF49 3?42 (0?64) **
ORF50 4?91 (0?56) **
ORF51 7?53 (0?55)
ORF52 7?35 (0?51)
ORF53 9?88 (0?53) **
ORF54 7?87 (0?86)
ORF55 0?35 (0?89)
ORF56 20?38 (0?51)
ORF57 4?93 (0?56) **
ORF58 6?16 (0?54) **
ORF59 0?81 (0?70)
ORF60 0?45 (0?68)
ORF61 10?80 (0?49) **
ORF62 5?68 (0?49)
ORF63 2?43 (0?43) **
ORF64 3?47 (0?54) **
ORF65 9?17 (0?73)
ORF66 7?32 (0?62)
ORF67 3?17 (0?52)
ORF68 10?93 (0?63) **
ORF69 4?21 (0?70)
ORF70 5?10 (0?89) **
ORF71 9?21 (1?04)
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et al., 2001). The oligonucleotide probes selected provide
a global and simultaneous readout of VZV ORF tran-
scriptional activity. In addition, transcriptional polarity is
defined, since the probes are single stranded and of sense
orientation. However, the probes were not designed to
address the fine details of VZV transcriptional complexity.
Indeed, a limitation of this approach is that the array probes
do not allow for the differentiation of co-terminal and col-
linear transcripts, which is a feature of VZV transcription. In
this respect, certain probes (e.g. for ORFs 4/5 and 63/64)
probably detect multiple transcripts arising from the same
strand.
The six most abundant VZV transcripts detected in MeWo
cells infected by the laboratory-adapted Dumas VZV strain
were ORFs 57, then 9, 49, 58, 48 and 69. Four of these ORFs
were also in the top six transcribed genes in the study of
Cohrs et al. (2003b), namely ORFs 9, 49, 57 and 69 (ORF 64
was highly expressed in the previous study, andORFs 64 and
69 are duplicated genes). The HSV 1 homologue of the
protein encoded by ORF 49 has been identified as a virion
protein (MacLean et al., 1989), while the protein encoded
by ORF 57 is a hypothetical protein, which has yet to be
identified but is dispensable for virus replication in cell
culture (Cox et al., 1998). ORF 33, which encodes a protease
(McMillan et al., 1997), was not significantly expressed in
MeWo cells, despite being highly expressed in BSC-1 cells
infected with VZV Ellen (Cohrs et al., 2003b). ORF 64/69
encodes a 19?8 kDa protein which is dispensable for
virus replication (Sommer et al., 2001). Despite the not-
unexpected differences, these transcriptional similarities
between the two systems reinforce the reliability of micro-
array technology.
Both the cell type used for infection (MeWo versus BSC-1)
and the strain of virus used (Dumas versus Ellen) were
different in the Cohrs et al. (2003b) study and this study,
and this is presumably a major contributing reason for the
differences observed. In our study, the transcriptome of
VZV Dumas strain on either the MeWo cells (known to
be VZV-permissive) or SVG cells was analysed at 72 h and
found to differ markedly, as shown in Table 5. Since the
same virus was used in both cases, and the ratio between
the top 20% of viral and invariant cellular genes was
equivalent, we conclude that the infected host-cell type
influences the viral transcriptome. It is known that dur-
ing acute VZV infection of cultured human astroglial cells,
host-protein synthesis may be altered, as evidenced by the
down-regulation of glial fibrillary acidic protein (GFAP)
under these conditions (Kennedy et al., 1994). Since SVG
cells are also astroglial, it is possible that some form of
host-cell modulation by the infection may have affected
the virus–host cell interaction to produce the observed
phenotype.
Table 5. Highly significant fold changes that are equivalently expressed between 72 h post-
infection (Dumas strain) SVG cells and MeWo cells
The VZV ORFs in this table with assigned functions are 13, 18, 29, 33, 37, 47, 49, 61, 63/70 and 68.
The rest are assumed functions.
ORF Fold change infected
versus uninfected SVG
cells (standard error)
ORF function Fold change infected versus
uninfected MeWo cells
(standard error)
ORF13 10?37 (0?72) Thymidylate synthase 8?69 (0?37)
ORF18 9?69 (0?87) Ribonucleotide reductase, small subunit 12?30 (0?32)
ORF20 9?46 (0?85) Capsid protein 10?47 (0?36)
ORF23 3?44 (0?61) Capsid protein 13?82 (0?37)
ORF24 11?09 (0?48) Membrane-associated phosphoprotein 13?41 (0?41)
ORF29 8?96 (0?74) ssDNA binding protein 11?97 (0?46)
ORF32 10?41 (0?47) Hypothetical protein 12?71 (0?39)
ORF33 7?86 (0?67) Protease 13?05 (0?42)
ORF37 5?02 (0?53) Glycoprotein H 12?98 (0?47)
ORF47 8?77 (0?68) Serine/threonine protein kinase 11?36 (0?35)
ORF49 3?42 (0?64) Myristylated virion protein 14?32 (0?34)
ORF50 4?91 (0?56) Glycoprotein M 12?48 (0?34)
ORF53 9?88 (0?53) Hypothetical protein 12?73 (0?41)
ORF57 4?93 (0?56) Hypothetical protein 14?49 (0?44)
ORF58 6?16 (0?54) Nuclear phosphoprotein 14?26 (0?37)
ORF61 10?80 (0?49) Transactivator 13?52 (0?37)
ORF63 2?43 (0?43) Transactivator/transrepressor 5?95 (0?39)
ORF64 3?47 (0?54) Virion protein 9?48 (0?37)
ORF68 10?93 (0?63) Glycoprotein E 10?44 (0?40)
ORF70 5?10 (0?89) Transactivator/transrepressor 13?64 (0?34)
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To date we, and others, have performed a large number of
diverse microarray studies of herpesvirus family genomes,
including the analysis of a wide range of different strains and
mutant genomes (Chambers et al., 1999; Ebrahimi et al.,
2003; Jenner et al., 2001; Stingley et al., 2000; Sun et al.,
2004; Wagner et al., 2002; Yang et al., 2002). Overall, these
experiments reveal a marked robustness of the herpes viral
transcription programme. A key property of robust systems
is their general insensitivity to changes of internal para-
meters.We also have preliminary data (P. G. E. Kennedy and
others, unpublished results), based on two different VZV
patient isolates, that suggest that the viral RNA tran-
scriptional signatures may differ markedly from patient to
patient, but much further work will be required to deter-
mine whether this can be used as a potential correlate or
predictor of the development of PHN. Both oligonucleo-
tide- and PCR-based VZV arrays are very likely to prove
powerful tools for the future investigation of viral gene
function, and may also have diagnostic potential.
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